Neuronal GABA B receptors regulate calcium and potassium currents via G-protein-coupled mechanisms and play a critical role in long-term inhibition of synaptic transmission in the CNS. Recent studies have demonstrated that assembly of GABA B receptor GABA B R1 and GABA B R2 subunits into functional heterodimers is required for coupling to potassium channels in heterologous systems. However whether heterodimerization is required for the coupling of GABA B receptors to effector systems in neurons remains to be established. To address this issue, we have studied the coupling of recombinant GABA B receptors to endogenous Ca 2ϩ channels in superior cervical ganglion (SCG) neurons using nuclear microinjection to introduce both sense and antisense expression constructs. Patchclamp recording from neurons injected with both GABA B R1a/1b and GABA B R2 cDNAs or with GABA B R2 alone produced marked baclofen-mediated inhibition of Ca 2ϩ channel currents via a pertussis toxin-sensitive mechanism. The actions of baclofen were blocked by CGP62349, a specific GABA B antagonist, and were voltage dependent. Interestingly, SCGs were found to express abundantly GABA B R1 but not GABA B R2 at the protein level. To determine whether heterodimerization of GABA B R1 and GAB-A B R2 subunits was required for Ca 2ϩ inhibition, the GABA B R2 expression construct was microinjected with a GABA B R1 antisense construct. This resulted in a dramatic decrease in the levels of the endogenous GABA B R1 protein and a marked reduction in the inhibitory effects of baclofen on Ca 2ϩ currents. Therefore our results suggest that in neurons heteromeric assemblies of GABA B R1 and GABA B R2 are essential to mediate GABAergic inhibition of Ca 2ϩ channel currents.
Neuronal GABA B receptors regulate calcium and potassium currents via G-protein-coupled mechanisms and play a critical role in long-term inhibition of synaptic transmission in the CNS. Recent studies have demonstrated that assembly of GABA B receptor GABA B R1 and GABA B R2 subunits into functional heterodimers is required for coupling to potassium channels in heterologous systems. However whether heterodimerization is required for the coupling of GABA B receptors to effector systems in neurons remains to be established. To address this issue, we have studied the coupling of recombinant GABA B receptors to endogenous Ca 2ϩ channels in superior cervical ganglion (SCG) neurons using nuclear microinjection to introduce both sense and antisense expression constructs. Patchclamp recording from neurons injected with both GABA B R1a/1b and GABA B R2 cDNAs or with GABA B R2 alone produced marked baclofen-mediated inhibition of Ca 2ϩ channel currents via a pertussis toxin-sensitive mechanism. The actions of baclofen were blocked by CGP62349, a specific GABA B antagonist, and were voltage dependent. Interestingly, SCGs were found to express abundantly GABA B R1 but not GABA B R2 at the protein level. To determine whether heterodimerization of GABA B R1 and GAB-A B R2 subunits was required for Ca 2ϩ inhibition, the GABA B R2 expression construct was microinjected with a GABA B R1 antisense construct. This resulted in a dramatic decrease in the levels of the endogenous GABA B R1 protein and a marked reduction in the inhibitory effects of baclofen on Ca 2ϩ currents. Therefore our results suggest that in neurons heteromeric assemblies of GABA B R1 and GABA B R2 are essential to mediate GABAergic inhibition of Ca 2ϩ channel currents.
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GABA B receptors play a critical role in long-term inhibition of synaptic transmission in the CNS (Bowery, 1993; Mott and Lewis, 1994) . Inhibition is mainly achieved via modulation of neurotransmitter release from presynaptic terminals and hyperpolarization of postsynaptic membranes. Although activation of inwardly rectifier potassium channels (GIRKs) is thought to be responsible for a GABA B -mediated membrane hyperpolarization, inhibition of presynaptic N-type Ca 2ϩ channels is thought to be responsible for modulation of neurotransmitter release (Mott and Lewis, 1994; Kaupmann et al., 1998; Takahashi et al., 1998) . The regulation of GABA B receptor function has been implicated in cognition enhancement and induction of long-term potentiation (Davies et al., 1991; Olpe et al., 1993) . In addition, involvement of the GABA B receptor in a number of diseases of the CNS such as epilepsy, anxiety, depression, and cognitive deficits make it an attractive target for therapeutic agents (Bittiger et al., 1993; Kerr and Ong, 1995; Dichter, 1997) .
The first GABA B receptors, GABA B R1a and GABA B R1b, were cloned from a mouse cortical and cerebellar cDNA library (Kaupmann et al., 1997) . They exhibited a low affinity for agonists and did not couple efficiently to neuronal Ca 2ϩ channels when expressed heterologously in sympathetic neurons (Couve et al., 1998) . Subcellular distribution of epitope-tagged GABA B R1 demonstrated that recombinant receptors failed to reach the cell surface and were retained in intracellular compartments when expressed in a variety of neuronal and non-neuronal cell types. These results provided an explanation for the lack of function of recombinant GABA B R1 receptors in coupling to other effector systems such as K ϩ channels (Couve et al., 1998) . Recently GABA B R2, a second receptor ϳ35% identical to GABA B R1, has been identified by several laboratories (Jones et al., 1998; Kaupmann et al., 1998; White et al., 1998; Kuner et al., 1999) . Unexpectedly for a G-protein-coupled receptor, heteromeric assembly of GABA B R1 and GABA B R2 has been shown to be necessary for coupling to adenylyl cyclase and activation of GIRKs in Xenopus oocytes and human embryonic kidney 293 (HEK293) cells (Jones et al., 1998; Kaupmann et al., 1998; White et al., 1998; Kuner et al., 1999) . However, it has yet to be determined whether heterodimer formation is required for coupling to their effector systems (such as Ca 2ϩ channels) in neurons. Here we demonstrate that the heteromeric assembly of GABA B R1 and GABA B R2 receptor subunits is required to allow GABA B receptor-induced inhibition of Ca 2ϩ currents in rat superior cervical ganglion (SCG) neurons.
MATERIALS AND METHODS
Neuron preparation and cDNA injection. Neuron isolation and injection procedures have been described previously in detail (Filippov et al., 1997 Couve et al., 1998) . Briefly, single SCG neurons were dissociated from 15-to 19-d-old rats and plated on laminin-coated glass coverslips. Five hours after plating, neurons were microinjected into the nucleus with plasmids carrying cDNAs of the GABA B receptor subunits. Plasmids were stored at 4°C as 1 g/l stock solutions in 10 mM TRIS and 1 mM EDTA, pH 8, and injected at a final pipette concentration of 0.15-0.5 g/l. (E xperimental data were indistinguishable over this range of concentrations for GABA B R1a and GABA B R1b.) Neurons were coinjected with cDNA for the "enhanced" S65T mutant of jellyfish green fluorescent protein (GFP) at concentrations of 0.01-0.5 g/l for later identification of the cells with successf ully expressed cDNAs. For controls, neurons were injected with GFP cDNA alone or not injected at all. After injections, cells were incubated for 14 -48 hr in a humidified incubator (5% C O 2 /95% O 2 ) at 37°C. Injected neurons with successf ully expressed cDNAs were identified as bright fluorescent cells using an inverted microscope (Diaphot 200; Nikon) equipped with an epifluorescent block N B2E (Nikon). Electrophysiological recordings were routinely made 16 -20 hr after injection at room temperature (20°C). In some experiments, recordings were made 40 hr after injections. Where indicated, neurons were incubated for 12-16 hr with pertussis toxin (P TX; 0.5 g/l) added to the culture media.
Plasmids. A cytomegalovirus (C M V) promoter-based mammalian expression vector containing a myc-tagged version of the rat GABA B R1a receptor has been described previously (Couve et al., 1998) . The GABA B R1a antisense cDNA was obtained by subcloning the sequence of the complete receptor in the opposite orientation with its 3Ј end facing the C M V promoter. A GABA B R2 receptor plasmid was obtained by subcloning an ϳ3.5 kb XbaI containing the sequence of the rat GAB-A B R2 receptor from pC1-Neo/GABA B R2 (kindly provided by Dr. Bernhard Bettler) into a C M V promoter-based mammalian expression vector.
Antibodies. A guinea pig pan antibody directed against the C -terminal domain of GABA B R1a was obtained from Chemicon International. A rabbit antibody specific for GABA B R1a was raised against the peptide CHPPW EGGIRYRGLTRDQV K from the N-terminal domain of GABA B R1a conjugated with keyhole limpet hemocyanin and was immunopurified using the same peptide. A rabbit antibody directed against the C -terminal domain of GABA B R2 was kindly provided by Dr. Bernhard Bettler. M AP2 monoclonal antibody was obtained from Sigma (St. L ouis, MO). Monoclonal protein disulfide isomerase (DPI) antibody was purchased from Stress Gen. Synaptophysin antibody was kindly provided by Dr. Dan Cutler. Texas Red-and fluorescein-conjugated anti-rabbit and anti-mouse secondary antibodies were purchased from Jackson ImmunoResearch (West Grove, PA). Ca 2ϩ channel current recording. Currents through voltage-gated C a 2ϩ channels were recorded using the conventional whole-cell patch-clamp method as described previously (C aulfield et al., 1994) . C ells were superf used (20 -25 ml /min) with a solution consisting of 120 mM tetraethylammonium chloride, 3 mM KC l, 1.5 mM MgC l 2 , 5 mM BaC l 2 , 10 mM H EPES, 11.1 mM glucose, and 0.5 M tetrodotoxin. The pH was adjusted to 7.35 with NaOH. Patch electrodes (2-3 M⍀) were filled with a solution containing 110 mM CsCl, 3 mM MgC l 2 , 40 mM H EPES, 3 mM EGTA, 2 mM Na 2 ATP, and 0.5 mM Na 2 GTP, with pH adjusted to 7.4 with C sOH. Neurons were voltage-clamped using a discontinuous ("switching") amplifier (Axoclamp 2B) sampling voltage at 6 -8 kHz (50% duty cycle). Commands were generated via a Digidata 1200 interface using "C lamp 6" computer software (Axon Instruments, Foster C ity, CA). C a 2ϩ channel currents were routinely evoked every 20 sec with a 100 msec depolarizing rectangular test pulse to 0 mV from a holding potential of Ϫ90 mV. Currents were digitized and stored on a computer for later analysis using C lamp 6 software. C a 2ϩ channel current amplitudes were measured isochronally 10 msec from the onset of the rectangular test pulse, i.e., near the peak of the control current. To eliminate leak currents, Co 2ϩ was substituted for Ba 2ϩ in the external solution at the end of each experiment, blocking all C a 2ϩ channel currents, and the residual current was digitally subtracted from the corresponding currents in the Ba 2ϩ solution. As reported previously (Filippov et al., 1997 , currents were primarily N-type with negligible contribution by L -type channels.
Data were presented as means Ϯ SEM as appropriate. Student's test (unpaired) was applied to determine statistical significance. The difference was considered significant if p Յ 0.05.
Baclofen and norepinephrine were purchased from Sigma. P TX was obtained from Porton Products (Dorset, UK).
Protein e xtracts, immunoblots, and immunofluorescence. Immunofluorescence and immunoblots were performed as described previously (Couve et al., 1998) . For preparation of brain membranes, fresh rat brains were homogenized in 10 vol of 5 mM Tris-C l, pH 7.4, 0.32 M sucrose, and a cocktail of protease inhibitors with 50 strokes using a glass and Teflon homogenizer. The suspension was centrif uged at 1000 ϫ g for 15 min. The pellet was discarded, and the resulting supernatant was centrif uged at 17000 ϫ g for 30 min. The pellet was washed twice in 50 mM Tris-C l, pH 7.4, and resuspended at ϳ5 mg /ml in the same buffer. Aliquots were frozen and stored at Ϫ20°C until used. E xtracts from superior cervical ganglia were prepared by homogenizing ganglia in RI PA buffer containing 50 mM Tris-C l, 1 mM EDTA, 2 mM EGTA, 10 mM Na ϩ pyrophosphate, 1 mM Na ϩ orthovanadate, 50 mM NaF, 150 mM NaC l, 1% N P-40, 0.5% deoxychoic acid 0.1% SDS, and a cocktail of protease inhibitors. All extracts were stored at Ϫ20°C and mixed with SDS sample buffer before loading onto SDS-PAGE.
RESULTS
Heterologously expressed GABA B R1 and GABA B R2 or GABA B R2 but not GABA B R1 couple to N-type Ca
2؉ channels in sympathetic neurons
It has been reported previously that baclofen, a well characterized GABA B agonist, produced only a minor inhibition of Ca 2ϩ channel current in neurons injected exclusively with GABA B R1 cDNA, for greater than that (12.7 Ϯ 3.2%) in control neurons injected with GFP cDNA (Couve et al., 1998) . This lack of functional inhibition of Ca 2ϩ currents in SCG is in agreement with the endoplasmic reticulum retention of GABA B R1 after homomeric expression in neurons. In neurons injected with cDNAs for GABA B R1a and GABA B R2, bath application of 50 M baclofen produced a substantial and reversible inhibition of Ca 2ϩ channel current (recorded using Ba 2ϩ as the charge carrier) (Fig. 1 A) . This inhibition was accompanied by a currentonset slowing similar to that reported after activation of many other endogenous or heterologously expressed G-protein-coupled receptors in SCG neurons (Hille, 1994; Ikeda et al., 1995; Filippov et al., 1998 Filippov et al., , 1999 . Bath application of 1 M CGP62349, a specific antagonist of GABA B receptors (Billinton et al., 1999) , blocked the effect of baclofen (Fig. 1C,D) . Interestingly, washing out of the agonist produced an initial over-recovery of the current followed by a slow return to the control level [as reported for some other receptors (see Meza et al., 1999) ].
To study the requirement of heterodimer formation in the ability of recombinant GABA B receptors to couple to Ca 2ϩ channels, GABA B R2 cDNA, in the absence of GABA B R1, was injected into SCG neurons. Surprisingly, Ca 2ϩ channel currents were also inhibited in neurons injected exclusively with GAB-A B R2. This effect was indistinguishable from that obtained after coexpression of GABA B R1 and GABA B R2 (Fig. 1 B) . Thus, the mean inhibition of Ca 2ϩ channel current (measured 10 msec after onset of the test pulse) by 50 M baclofen was 56.1 Ϯ 3.2% for neurons expressing recombinant GABA B R1 and GABA B R2 and 52.3 Ϯ 4.8% for neurons expressing recombinant GABA B R2 exclusively (Fig. 1 D) .
GABA B -mediated inhibition of Ca
2؉ current is strongly voltage dependent, suggesting involvement of the Gprotein ␤␥ subunit Slowing of the current onset by baclofen in neurons with heterologously expressed GABA B R1 and GABA B R2 or GABA B R2 indicated that GABA B receptor-mediated inhibition of Ca 2ϩ channel current was voltage dependent and relieved during depolarization (cf. Bean, 1989) , as reported previously for other G-protein-coupled receptors. Indeed, a double-pulse protocol demonstrated that inhibition of Ca 2ϩ current produced by baclofen was greatly reduced after a 120 mV depolarizing prepulse (Fig. 2 A) . The prepulse also abolished the slowing of the current onset produced by baclofen. Identical results were obtained with both heterologously expressed GABA B R1 and GABA B R2 or GABA B R2 receptors. Inhibition was reduced from 58.7 Ϯ 2.4 to 15.2 Ϯ 4.7% in neurons with heterologously expressed GABA B R1 and GABA B R2 and from 50.2 Ϯ 3.8 to 14.1 Ϯ 1.8% in neurons expressing GABA B R2 (Fig. 2 B) . A similar effect was reported for the modulation of Ca 2ϩ current by endogenous GABA B receptors in sensory neurons and in calyx nerve terminals of the mammalian auditory brainstem (Grassi and Lux, 1989; Isaacson, 1998) . Similar voltage-dependent effects have been generally interpreted as produced by a direct interaction of G-protein ␤␥ subunits with an ␣ subunit of the Ca 2ϩ channel (Dolphin, 1995; Herlitze et al., 1996; Ikeda, 1996; Jones and Elmslie, 1997; Delmas et al., 1998a,b) .
A PTX-sensitive G-protein mediates Ca 2؉ current inhibition after activation of recombinant GABA B R1 and GABA B R2 or GABA B R2 receptors A strong voltage dependency of Ca 2ϩ channel current inhibition by baclofen in our experiments suggested that the recombinant GABA B receptors coupled to Ca 2ϩ channels via PTX-sensitive G-proteins (for review, see Hille, 1994) . Therefore, to determine the identity of the G␣-protein that mediates the Ca 2ϩ current inhibition in SCG neurons, responses to baclofen were determined after pretreatment with PTX. Indeed, after PTX pretreatment (500 ng/ml), baclofen no longer inhibited Ca 2ϩ channel currents in neurons expressing recombinant GABA B R1 and GABA B R2 receptors. PTX sensitivity was identical when cells expressing recombinant GABA B R2 were studied. These observations are summarized in Figure 3B . Taken together they clearly indicate that PTX pretreatment prevents Ca 2ϩ channel current inhibition in neurons expressing recombinant GABA B R1 and GABA B R2 or GABA B R2 alone (Fig. 3) . These results strongly suggest that only PTX-sensitive G-proteins mediate Ca 2ϩ current inhibition after activation of recombinant GABA B receptors. The complete disappearance of the baclofen response in the presence of PTX was unique to GABA B receptors because the same concentration of PTX was not capable of totally abolishing the response of endogenous ␣-adrenergic receptors to norepinephrine (Fig. 3A) . The small PTX-insensitive effect of norepi- nephrine is in agreement with a minor involvement of PTXinsensitive G-proteins in adrenergic receptor-mediated function (Hille, 1994; Delmas et al., 1999) .
Heteromeric assembly of GABA B R1 with GABA B R2 is required to couple effectively to Ca
2؉ channels in neurons
The results presented above showing the strong inhibition of Ca 2ϩ channel currents by GABA B R2 cDNA alone were of interest because heterologous expression of GABA B R2 is not sufficient to produce functional coupling to adenylyl cyclase or inward rectifier potassium channels in Xenopus oocytes or HEK293 cells (Jones et al., 1998; Kaupmann et al., 1998; White et al., 1998) . One possible explanation is that SCG neurons express endogenous GABA B R1 subunit that is not functionally coupled to Ca 2ϩ channels but that, on expression of GABA B R2, coassembles with recombinant GABA B R2 to constitute a functional heteromeric receptor indistinguishable from a recombinant dimer. Several experiments were designed to test this hypothesis.
First, the expression of GABA B R1 and GABA B R2 was analyzed in SCG neurons via immunoblotting with specific antibodies against these proteins. A specific antibody was raised against a peptide in the N-terminal domain of the GABA B R1a receptor, and expression of recombinant GABA B R1 was used to test the specificity of this antisera. In agreement with previous observations, the antibody recognized GABA B R1a as two specific bands in cell lysates derived from transfected COS cells. A lower band of ϳ120 kDa represents the monomeric receptor, and an ϳ250 kDa band presumably corresponds to receptor aggregates (Fig.  4 A, lane 1) . In contrast, a single ϳ120 kDa band is detected in crude brain membranes in agreement with previous observations (Fig. 4 A, lane 2) . Interestingly, low levels of an ϳ120 kDa band corresponding to the GABA B R1a protein were detected in SCG extracts. Unexpectedly, an aggregate form of the GABA B R1a protein was predominant in these cell lysates (Fig. 4 A, lane 3) . This band matches the ϳ250 kDa form of GABA B R1a observed in transfected COS cells. The specificity of the GABA B R1a antibody was demonstrated by competition with a GABA B R1 peptide before immunoblotting (Fig. 4 A, lane 4 ) . Second, to determine the expression of GABA B R2 in SCG, immunoblots with antibodies against GABA B R2 were performed. A single band of ϳ110 kDa was detected in crude brain membranes (Fig. 4 B, top) . SCG extracts showed no detectable levels of GABA B R2 (Fig. 4 B, top ). An immunoblot with antisynaptophysin antibodies indicates that protein levels and the integrity of cell extracts were similar between brain and SCG preparations (Fig. 4 B, bottom) . These observations were confirmed by detection of GABA B R1 (see Fig. 6 ) but not GABA B R2 (data not shown) by immunofluorescence in SCG neurons.
To investigate further the inhibition of Ca 2ϩ current by GABA B receptor subunits in neurons, the effects of baclofen on expressed GABA B R1 and GABA B R2 or GABA B R2 receptors were studied in detail using full dose-response curves. Baclofen inhibited Ca 2ϩ currents more effectively and with higher potency in cells expressing GABA B R1 and GABA B R2 receptors than in cells expressing only heterologous GABA B R2 receptors (Fig.  5A) . The IC 50 for inhibition was 0.09 Ϯ 0.01 M for GABA B R1 and GABA B R2 and approximately four times higher (0.38 Ϯ 0.05 M) for GABA B R2. To confirm these observations using a different methodology, SCG neurons were injected either with GABA B R2 cDNA or with an equal mixture of GABA B R2 cDNA and GABA B R1 antisense cDNA to reduce the expression of endogenous GABA B R1 protein. As expected, immunofluorescence with GABA B R1 antibodies revealed detectable levels of GABA B R1 in all sympathetic neurons, and levels were reduced in cells injected with GFP and GABA B R1 antisense cDNA (Fig. 5C,  top left, arrowhead) . Furthermore, coexpression of the sense and antisense cDNAs of GABA B R1 resulted in a significant decrease in expression of recombinant GABA B R1 protein (data not shown). Control cells injected with GFP alone showed no difference in expression of GABA B R1 (Fig. 5C, bottom left, arrowhead) . In accordance with these observations, inhibition of Ca 2ϩ channel currents in neurons injected with GABA B R1 antisense cDNA was significantly lower than inhibition in control neurons for all effective doses of baclofen (Fig. 5B) .
Taken together, the results presented above indicate that SCG neurons contain detectable levels of GABA B R1a and suggest that responses to baclofen in neurons injected with GABA B R2 result from activation of a heterodimer formed between endogenous GABA B R1a and recombinant GABA B R2 receptors. Interestingly, trace levels of GABA B R2 were observed occasionally in SCG extracts. This might generate trace levels of endogenous GABA B R1/R2 dimer and hence provide an explanation for the low response of control SCG neurons to baclofen (Fig. 1 D) .
Endogenous GABA B R1 is predominantly localized to the endoplasmic reticulum in SCG neurons
As reported previously, recombinant GABA B R1 receptors are retained in an intracellular compartment when expressed in neuronal and non-neuronal cell types (Couve et al., 1998) . To determine whether endogenous GABA B R1 receptors failed to reach the cell surface in SCG neurons, immunofluorescence with GABA B R1 antibodies was performed. The GABA B R1 receptor was found mainly restricted to the cell body of SCG neurons (Fig.  6 A, left) . Detection of MAP2, a somatodendritic marker, shows a different distribution pattern with predominant staining in cell projections (Fig. 6 A) . The pattern difference is still apparent after the levels of fluorescence have been equalized.
To determine the subcellular distribution of GABA B R1, SCG neurons were stained for GABA B R1 and DPI, an endoplasmic reticulum marker. DPI is present in neuronal and non-neuronal cell types from the SCG preparation (Fig. 6 B) . In contrast, GABA B R1 is present exclusively in neurons, and it overlaps almost entirely with DPI in these cells. These observations strongly suggest that both proteins colocalize in the endoplasmic reticulum.
GABA B R1 is localized to the plasma membrane after coexpression of GABA B R2
To provide additional evidence of the formation of functional, cell surface heterodimers after expression of GABA B R2, SCG neurons were microinjected with GABA B R1 or GABA B R2 independently or with GABA B R1 and GABA B R2 simultaneously. As reported previously (Couve et al., 1998) , a myc-tagged version of GABA B R1 is retained intracellularly in SCG neurons (Fig. 7,  top) . In contrast, a FLAG-tagged version of GABA B R2 is targeted efficiently to the cell surface (Fig. 7, middle) . Consistent with our electrophysiological findings, expression of GABA B R2 changes the subcellular distribution of GABA B R1 from the endoplasmic reticulum to the plasma membrane (Fig. 7, bottom) . These observations support the idea that GABA B R2 rescues GABA B R1 from intracellular compartments and strongly suggest that heterodimer formation is a requirement for GABA B receptor function.
DISCUSSION
In this report we demonstrate that coexpressed GABA B R1 and GABA B R2 subunits produce a functional receptor in sympa- Figure 5 . Heteromeric assembly of GABA B R1 with GABA B R2 is required to couple effectively to Ca 2ϩ channels in neurons. A, B, Plots show the concentration dependence of Ca 2ϩ current inhibition by baclofen in SCG neurons injected with GABA B R1 cDNA ϩ GABA B R2 cDNA (R1ϩR2) or GABA B R2 cDNA (R2) ϳ16 -20 hr before recordings ( A) or with GABA B R2 cDNA (R2) or GABA B R2 cDNA ϩ GABA B R1 antisense cDNA (R2ϩantisense R1) ϳ40 hr before recordings ( B). Curves were fitted to pooled data points (mean Ϯ SEM) using Origin 4.1 software to the Hill equation: y ϭ y max .x nH /(x nH ϩ K nH ), where y is the observed percent inhibition, y max is the extrapolated maximal percent inhibition, x is the baclofen concentration (micromolar), K is the IC 50 (micromolar), and n H is the Hill coefficient. A, For R1ϩR2, IC 50 ϭ 0.09 Ϯ 0.01 M; Hill coefficient ϭ 1.00 Ϯ 0.13; and maximal inhibition ϭ 55.55 Ϯ 1.68%. For R2, IC 50 ϭ 0.38 Ϯ 0.05 M; Hill coefficient ϭ 1.30 Ϯ 0.20; and maximal inhibition ϭ 52.55 Ϯ 1.90%. B, For R2, IC 50 ϭ 0.34 Ϯ 0.04 M; Hill coefficient ϭ 1.66 Ϯ 0.28; and maximal inhibition ϭ 60.14 Ϯ 2.30%. For R2ϩantisense R1, IC 50 ϭ 0.66 Ϯ 0.15 M; Hill coefficient ϭ 1.14 Ϯ 0.24; and maximal inhibition ϭ 37.93 Ϯ 1.92%. Note that heterologously coexpressed GABA B R1 and GABA B R2 inhibit Ca 2ϩ current more effectively than does heterologously expressed GABA B R2 and that reduction of endogenous GABA B R1 expression by antisense cDNA significantly reduces inhibition of Ca 2ϩ current. C, Immunofluorescence with GABA B R1 antibodies in cells injected with GABA B R1 cDNA antisense is shown. Cells were injected with either GFP (bottom panels) or GFP plus GABA B R1a antisense (top panels) cDNA. Right panels show GFP fluorescence of injected neurons. Left panels show the same neurons stained for GABA B R1. In both cases the leftmost cell has been injected (arrowheads), whereas the rightmost cell has not (arrows). Only cells injected with GABA B R1 antisense cDNA show a decrease in GABA B R1 expression when compared with noninjected cells. thetic neurons that couples effectively to N-type Ca 2ϩ channels. Thus, heteromeric assembly of GABA B R1 and GABA B R2 receptor subunits appears to be necessary for coupling to all three known effectors: Ca 2ϩ channels, adenylyl cyclase, and inward rectifier K ϩ channels (Jones et al., 1998; Kaupmann et al., 1998; White et al., 1998) . It might be noted, however, that the IC 50 for inhibition of the Ca 2ϩ current in sympathetic neurons (ϳ90 nM) was appreciably lower than that required to inhibit GIRK channels in non-neuronal cells, suggesting that expression of GABA B receptor dimers in their natural (neuronal) environment allows more effective ion channel coupling.
To the degree that the present experiments allow, the mechanism by which these exogenously expressed receptors inhibit neuronal Ca 2ϩ channels appears identical to that used by native GABA B receptors present in other neurons. Thus, inhibition was strongly reduced by pertussis toxin, implying mediation by members of the G i /G o family of G-proteins [probably G o (see Campbell et al., 1993; Menon-Johansson et al., 1993) ]. Also, the strong voltage dependence of inhibition in sympathetic neurons accords with previous observations on sensory neurons (Grassi and Lux, 1989) , suggesting that it was mediated by ␤␥ subunits of the G-protein (Dolphin, 1995; Jones and Elmslie, 1997) . Thus, our observations on the expression and functional coupling of recombinant GABA B receptors in sympathetic neurons are likely to be relevant to the properties of natively expressed receptors.
Immunoblot analysis demonstrated that the predominant form of GABA B R1 in SCG corresponds to a large ϳ250 kDa protein band. The nature of this high-molecular weight form of GABA B R1 is not known, but it is unlikely to correspond to receptor dimers because homomeric interactions have not been shown to occur (Fritschy et al., 1999) . A similar protein band is normally observed in other heterologous expression systems in which the GABA B R1 receptor is not functional (Couve et al., 1998) . We hypothesize that this structure corresponds to nonfunctional GABA B R1 receptor aggregates retained in the endoplasmic reticulum.
In this context, our experiments strongly suggest that GABA B R2 forms an essential subunit of the functional receptor and that it is required both for assembly and membrane insertion of the receptor. Thus, functional membrane receptors were generated not only by coexpression of recombinant GABA B R1 and GABA B R2 plasmids but also on expression of exogenous GABA B R2 subunits alone. We attribute this to coassembly with the native GABA B R1 subunits normally present in these sympathetic neurons, because reduction of GABA B R1 protein by antisense expression also reduced the response of GABA B R2-expressing cells to baclofen (Fig. 5) . Because GABA B R1 protein was predominantly confined to the endoplasmic reticulum, this also suggests that GABA B R2 plays a crucial role in trafficking and membrane insertion of the dimeric receptor. The fact that GABA B R2 is localized to the plasma membrane and traffics GABA B R1 in heterologous cells (White et al., 1998; Martin et al., 1999) and in SCG neurons supports these observations. Cultured SCG neurons respond poorly to GABA B agonists and are generally thought to be devoid of GABA B receptors. However, GABA B responses may appear as a result of GABA B R2 expression during pathology, in certain stages of development, or under specific and local stimuli. Our findings together with the fact that GABA B agonists have been shown to modify superior cervical ganglia after prolonged applications (Parducz et al., 1990) , that SCG neurons contain GABA A receptors (Brown et al., 1979) , and that SCG neurons are innervated by GABAergic terminals (Kasa et al., 1988) certainly suggest that GABA B receptors have the potential to function in sympathetic neurons. Nevertheless, the conditions under which GABA B receptors may be physiologically expressed remain to be determined. If this hypothesis is correct, other neuronal types might use a similar regulatory mechanism, in which expression of the GABA B R2 subunit or other accessory protein determines the formation of functional receptors by trafficking existent GABA B R1 from the endoplasmic reticulum to the plasma membrane.
In situ hybridization studies have revealed certain areas in the CNS where expression of GABA B R1 is much greater than GABA B R2 and others where GABA B R1 is present and GABA B R2 is not (Jones et al., 1998; Kaupmann et al., 1998; Martin et al., 1999) . These observations have led to the suggestion that GABA B R1 can function as a monomer or with accessory proteins other than GABA B R2 in some areas of the CNS (Marshall et al., 1999) . The fact that baclofen produced a small inhibition of the Ca 2ϩ current in sympathetic neurons in the absence of exogenous GABA B R2 subunits might appear to offer some support for this view. However, because trace levels of endogenous GABA B R2 protein were occasionally detected in SCG extracts, we cannot exclude the possibility that the small effects of baclofen on uninjected cells might have resulted from activation of a small number of endogenous GABA B R1/R2 dimers.
The question also arises whether GABA B R2 subunits might form functional receptors independent of GABA B R1 subunits. GABA B R2 has been reported to couple negatively to adenylyl cyclase in transfected COS cells (Martin et al., 1999) and HEK293 cells (Kuner et al., 1999) . However, the effectiveness of this coupling is under question because the baclofen concentrations used in these experiments were very high (300 -500 M; compared, for example, with an IC 50 of ϳ90 nM for Ca 2ϩ current inhibition mediated by GABA B R1 and GABA B R2 in the present experiments), and GABA B R2 does not couple to the inward rectifier GIRK channels coexpressed in Xenopus oocytes or HEK293 cells (Jones et al., 1998; Kaupmann et al., 1998; White et al., 1998; Kuner et al., 1999) . Our experiments with GABA B R1 antisense cDNA injections in SCG neurons confirm that responses apparently mediated by exogenous GABA B R2 receptors are primarily (and possibly entirely) caused by formation of GABA B R1/GABA B R2 dimers with endogenous GABA B R1 subunits. Nevertheless, more conclusive evidence is necessary to exclude the possibility that either GABA B R1 or GABA B R2 might be able to function independently. New subunit-specific agonists and definitive binding studies are necessary to resolve this issue.
Notwithstanding such considerations, the principal point emerging from the present experiments is that efficient coupling of GABA B receptors to Ca 2ϩ channels in sympathetic neurons requires the heteromeric assembly of both GABA B R1 and GABA B R2 subunits and therefore that this is likely to be true for those endogenous GABA B receptors responsible for Ca 2ϩ current inhibition (and resultant presynaptic inhibition) in other parts of the mammalian nervous system.
